Silmitasertib (CX-4945), a clinically used CK2-kinase inhibitor with additional effects on GSK3β and DYRK1A kinases: a structural perspective - Grygier, P; Pustelny, K; Nowak, J (Journal of Medicinal Chemistry, 2023)